UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Airomir0.1Spray-SE-PLC-RA

Generated Narrative: RegulatedAuthorization Airomir0.1Spray-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/12324

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00012324,http://ema.europa.eu/fhir/eurdId#10330; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Pressurised inhalation, suspension; indication = Airomir 0,1 mg/dos inhalationsspray, suspension är indicerat för symtomlindring av bronkkonstriktion vid astma och kroniskt obstruktiv lungsjukdom (KOL). Airomir är indicerat för vuxna, ungdomar och barn. För barn under 4 år ska dosering och farmakodynamik ses över.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = salbutamol

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 1996-04-03

holder: Organization Teva Sweden AB

Cases

-TypeDate[x]
*First Authorisation1996-04-03